Clostridium difficile: Back in Hospitals and Meaning Business

Clostridium difficile: Back in Hospitals and Meaning Business

0:00

Lance Peterson Lance Peterson, Evanston Northwestern Healthcare, Illinois The bacterium clostridium difficile that can cause diarrhoea in hospital patients is making a resurgence. It’s potential

Lance Peterson

Lance Peterson

Lance Peterson, Evanston Northwestern Healthcare, IllinoisThe bacterium clostridium difficile that can cause diarrhoea in hospital patients is making a resurgence. It’s potentially very aggressive, and it’s not so easy to detect any more. But a new real-time polymerase chain reaction (PCR) test reported at the ICAAC conference looking for genes involved with production of the C. difficile product: toxin B promises to help fight the problem.

Click here for all the interviews from ICAAC 2005

Related Episodes

Routine Angioplasty Recommended After Thrombolysis

Routine Angioplasty Recommended After Thrombolysis

Warren Cantor Tony Gershlick REFERENCE: Abstract 2404-3 SCAI-ACCi2 Late-Breaking Clinical Trials II: Acute Myocardial Infarction Warren Cantor, University of Toronto COMMENT: Tony Gershlick, Leicester

Debate: Adjuvant Chemotherapy Should Be Standard in Stage I Non-Small Cell Lung Cancer

Debate: Adjuvant Chemotherapy Should Be Standard in Stage I Non-Small Cell Lung Cancer

Giorgio Scagliotti Robert Pirker GIORGIO SCAGLIOTTI, University of Turin ROBERT PIRKER, Medical University of Vienna A heated debate took place at the European Congress on Lung Cancer in Turin between

Front Line Therapy in Non-Small Cell Lung Cancer

Front Line Therapy in Non-Small Cell Lung Cancer

Nick Thatcher NICK THATCHER, Christie Hospital, Manchester There is a proven benefit in survival if you give your patients cis-platinum based chemotherapy after resection for non-small cell lung cance